this guy is a #fake #cart #toon #ist pleaaaase rip him apart slowly
@toomanyhumans.net
@modvc.org🎨 Glass Gallery Spotlight: "3Girls & 4Boys"
@narrowit.bsky.socialIASO Bio Reports Early Responses in 10-Patient In Vivo CAR-T Study IASO Bio reported a 90% response rate in the first 10 evaluable multiple-myeloma patients treated with...
https://www.narrowit.com/news/iaso206-first-in-human-in-vivo-car-t-data-2026-09-27
#IasoBio #IASO206 #CART #MultipleMyeloma
@currentmedscience.bsky.socialBy analyzing #CD8+, CD4+, NKT, and γδ T cells, this study underscores the promise of TCR‑T, #CART, and checkpoint inhibitors in achieving long‑term AML control and advancing future therapeutic strategies. #medsky
To read: doi.org/10.1007/s115...
@stylelib.orgWooCommerce Ajax Cart Added To Cart Popup – Floating/Sliding/Popup All in One Cart/Checkout Plugin
@aiinmeditech.bsky.socialAn AI CAR-T Intelligence Platform can help strategy teams bring clinical, pipeline, competitive, and market signals into a more structured view.
CAR-T Navigator is built to support decision-making across the evolving cell therapy landscape.
@thesumairafdn.bsky.socialCould CAR T-cell therapy change the future of treatment for neuroimmune diseases? 🧬✨
🎥 Learn about #CART from experts Dr. Levy & Dr. Maus be sure to check out the webinar replay on YouTube!
www.youtube.com/watch?v=gTEK...
@aiinmeditech.bsky.socialExplore how CAR-T analytics software , pipeline tracking and competitive intelligence can help biopharma teams understand clinical development, competitors and emerging in-vivo CAR-T opportunities in 2026.
Read: justpaste.it/h5rud
@greyfoxbooks.bsky.socialFinally #lostsouls for the #c64 Cartridge edition is here form us here at @bitmapsoft.co.uk
Only 30 units available. This is ane exclusive release from the MegaStyle team. Sorry for the wait on this one everyone 🤝
Purchase here:
bitmapsoft.co.uk/product/lost-s…
@bio-integration.orgVHHNectin4 #CART cells are engineered for precision.
They expand CD4+ & memory T cells, secrete cytokines & kill Nectin4+ #BladderCancer cells without affecting Nectin4 negative cells, supporting translational promise. #medsky #Oncology
#BIOI #OpenAccess: doi.org/10.15212/bio...
@dctomaz.bsky.social🧬 CAR design includes its promoter. In 87 myeloma patients, cilta-cel tracked with a GZMK+ state; mouse experiments implicated EF1α in expansion and tumour control. Human comparison was non-randomised. doi.org/10.1038/s414... #CART
@mistbind.bsky.social
@axxur2.bsky.social
@beingexponential.bsky.social
@sfronnie.bsky.social
@maxmastall.bsky.social